Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05601544 · ClinicalTrials.gov registry record · NA
The Effects of Contact Lenses With UV/HEV-Filter on Visual Function
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT05601544 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 145 participants.
The verdict
NCT05601544, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
This is a 2-phase, single-site, non-dispensing, randomized, controlled, double-masked, 2x2 crossover study to objectively measure potential benefits of a new UV/HEV filter using psychophysical testing techniques.
Interventions
- DEVICE ACUVUE OASYS 1-Day for Astigmatism
- DEVICE ACUVUE OASYS 1-Day
- DEVICE ACUVUE OASYS MAX 1-Day
- DEVICE ACUVUE OASYS Multifocal
- DEVICE ACUVUE OASYS MAX 1-Day Multifocal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2022-12-09 |
| Est. Completion | 2023-11-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05601544
The ClinicalTrials.gov registry entry for NCT05601544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which ACUVUE OASYS 1-Day for Astigmatism is the first listed.
NCT05601544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05601544 about?
NCT05601544 is a clinical study titled "The Effects of Contact Lenses With UV/HEV-Filter on Visual Function". This is a 2-phase, single-site, non-dispensing, randomized, controlled, double-masked, 2x2 crossover study to objectively measure potential benefits of a new UV/HEV filter using psychophysical testing techniques.
What is the current status of trial NCT05601544?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2022-12-09. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT05601544?
The interventions under investigation include: ACUVUE OASYS 1-Day for Astigmatism (DEVICE), ACUVUE OASYS 1-Day (DEVICE), ACUVUE OASYS MAX 1-Day (DEVICE), ACUVUE OASYS Multifocal (DEVICE), ACUVUE OASYS MAX 1-Day Multifocal (DEVICE).
Who is sponsoring clinical trial NCT05601544?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.